EFFECTIVE SHARED CARE AGREEMENT OF LISDEXAMFETAMINE FOR THE TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) IN CHILDREN AND ADOLESCENTSEffective Shared Care Agreement • August 2nd, 2021
Specialist prescriber responsibilities 1 Discuss the benefits and side effects of treatment with the patient and carer (as appropriate).2 Check for possible drug interactions with lisdexamfetamine and patient’s regular medication. Avoid prescribing interacting drugs.3 Assess likelihood of compliance.4 Ensure patient and carer (as appropriate) are given sufficient information about their treatment.5 Perform all baseline tests as stated on the monitoring requirement.6 Initiate and stabilise treatment with lisdexamfetamine. Stabilisation will usually take 6- 12 weeks.7 Supply medication until care is transferred to GP.8 Ask the GP whether he or she is willing to participate in shared care and explain the intention to share care with patient/carer and obtain consent.9 Monitors appropriately as stated on the monitoring requirement.10 Inform GP of the dose to be prescribed, any changes in dose, when to stop treatment and when to refer the patient back to specialist.11 Physical health monitor
Effective Shared Care Agreement (ESCA)Effective Shared Care Agreement • November 27th, 2020
This shared care agreement outlines suggested ways in which the responsibilities for managing the prescribing of anti-dementia treatments can be shared between the specialist and general practitioner (GP). This agreement covers all single anti-dementia treatments.
Effective Shared Care Agreement (ESCA)Effective Shared Care Agreement • August 3rd, 2015
This shared care agreement outlines suggested ways in which the responsibilities for managing the prescribing of Azathioprine (in conjunction with prednisolone) for Interstitial lung disease can be shared between the specialist and general practitioner (GP). You are invited to participate however, if you do not feel confident to undertake this role, then you are under no obligation to do so. In such an event, the total clinical responsibility for the patient for the diagnosed condition remains with the specialist.
Effective Shared Care Agreement (ESCA)Effective Shared Care Agreement • December 19th, 2019
This shared care agreement outlines suggested ways in which the responsibilities for managing the prescribing of methotrexate for inflammatory arthritis can be shared between the specialist and general practitioner (GP). You are invited to participate however, if you do not feel competent to undertake this role, then you are under no obligation to do so. In such an event, the total clinical responsibility for the patient for the diagnosed condition remains with the specialist.
Effective Shared Care Agreement (ESCA)Effective Shared Care Agreement • May 16th, 2019
This shared care agreement outlines suggested ways in which the responsibilities for managing the prescribing of lisdexamfetamine in Attention-Deficit/Hyperactivity Disorder (ADHD) as part of a comprehensive treatment programme can be shared between the specialist and general practitioner (GP). You are invited to participate however, if you do not feel confident to undertake this role, then you are under no obligation to do so. In such an event, the total clinical responsibility for the patient for the diagnosed condition remains with the specialist.
Effective Shared Care Agreement (ESCA)Effective Shared Care Agreement • November 27th, 2020
This shared care agreement outlines suggested ways in which the responsibilities for managing the prescribing of subcutaneous denosumab injections for postmenopausal women with osteoporosis can be shared between the specialist and general practitioner (GP). You are invited to participate however, if you do not feel confident to undertake this role, then you are under no obligation to do so. In such an event, the total clinical responsibility for the patient for the diagnosed condition remains with the specialist. If a specialist asks the GP to prescribe and administer denosumab injection, the GP should reply to this request as soon as practicable.
Effective Shared Care Agreement (ESCA)Effective Shared Care Agreement • August 3rd, 2015
This shared care agreement outlines suggested ways in which the responsibilities for managing the prescribing of sodium clodronate for the management of osteolytic lesions, hypercalcaemia and bone pain associated with multiple myeloma or breast cancer can be shared between the specialist and general practitioner (GP). You are invited to participate however, if you do not feel confident to undertake this role, then you are under no obligation to do so. In such an event, the total clinical responsibility for the patient for the diagnosed condition remains with the specialist.
EFFECTIVE SHARED CARE AGREEMENT (Rifaximin)Effective Shared Care Agreement • November 24th, 2020
This shared care agreement outlines suggested ways in which the responsibilities for managing the prescribing of Rifaximin for reducing the recurrence of overt hepatic encephalopathy episodes in patients aged 18 years or older and can be shared between the specialist and general practitioner (GP). GPs are invited to participate. If the GP is not confident to undertake these roles, then he or she is under no obligation to do so. In that case, the total clinical responsibility for the patient for the diagnosed condition remains with the specialist. It is not acceptable for GPs to decline prescribing on the basis of cost alone. If a specialist asks the GP to prescribe this drug, the GP should reply to this request as soon as practicable.
Effective Shared Care AgreementEffective Shared Care Agreement • January 29th, 2016
EFFECTIVE SHARED CARE AGREEMENT (ESCA)Effective Shared Care Agreement • March 26th, 2021
At the last patient review the drug appeared to be effectively controlling symptoms / providing benefit: Yes / No (delete as appropriate).
Effective Shared Care Agreement (ESCA)Effective Shared Care Agreement • March 10th, 2022
This shared care agreement outlines suggested ways in which the responsibilities for managing the prescribing of melatonin in REM sleep behaviour disorder or circadian rhythm sleep-wake disorder in adults (off label indications) can be shared between the specialist and general practitioner (GP). You are invited to participate however, if you do not feel competent to undertake this role, then you are under no obligation to do so. In such an event, the total clinical responsibility for the patient for the diagnosed condition remains with the specialist.
Effective Shared Care Agreement (ESCA)Effective Shared Care Agreement • August 3rd, 2015
This shared care agreement outlines suggested ways in which the responsibilities for managing the prescribing of perampanel for epileptic seizures can be shared between the specialist and general practitioner (GP). You are invited to participate however, if you do not feel confident to undertake this role, then you are under no obligation to do so. In such an event, the total clinical responsibility for the patient for the diagnosed condition remains with the specialist.
Effective Shared Care Agreement (ESCA)Effective Shared Care Agreement • August 3rd, 2015
This shared care agreement outlines suggested ways in which the responsibilities for managing the prescribing of ulipristal acetate (Esmya) for pre-operative treatment of moderate to severe symptoms of uterine fibroids can be shared between the specialist and general practitioner (GP). You are invited to participate however, if you do not feel confident to undertake this role, then you are under no obligation to do so. In such an event, the total clinical responsibility for the patient for the diagnosed condition remains with the specialist.
Effective Shared Care Agreement (ESCA)Effective Shared Care Agreement • April 3rd, 2020
This shared care agreement outlines suggested ways in which the responsibilities for managing the prescribing lacosamide as adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older can be shared between the specialist and general practitioner (GP). You are invited to participate however, if you do not feel competent to undertake this role, then you are under no obligation to do so. In such an event, the total clinical responsibility for the patient for the diagnosed condition remains with the specialist.
Effective Shared Care Agreement (ESCA)Effective Shared Care Agreement • April 3rd, 2020
This shared care agreement outlines suggested ways in which the responsibilities for managing the prescribing of vigabatrin for epilepsy can be shared between the specialist and general practitioner (GP). You are invited to participate however, if you do not feel competent to undertake this role, then you are under no obligation to do so. In such an event, the total clinical responsibility for the patient for the diagnosed condition remains with the specialist.
Effective Shared Care Agreement (ESCA)Effective Shared Care Agreement • March 14th, 2017
This shared care agreement outlines suggested ways in which the responsibilities for managing the prescribing of midodrine for the management of severe orthostatic hypotension due to autonomic dysfunction when corrective factors have been ruled out and other forms of treatment are inadequate can be shared between the specialist and general practitioner (GP). You are invited to participate however, if you do not feel confident to undertake this role, then you are under no obligation to do so. In such an event, the total clinical responsibility for the patient for the diagnosed condition remains with the specialist.
Effective Shared Care Agreement for the treatment of Attention Deficit Hyperactivity disorder (ADHD) in children and adolescents with ATOMOXETINEEffective Shared Care Agreement • February 11th, 2015
Specialist responsibilities 1 Discuss the benefits and side effects of treatment with the patient and carer as appropriate.2 Check for possible drug interactions with atomoxetine and any other medication the patient might be on.3 Discuss the importance of compliance.4 Ensure patient and carers are given sufficient information about the treatment.5 Perform all baseline tests including mental health and social assessment, physical examination, including: assessment of history of exercise syncope, undue breathlessness and other cardiovascular symptoms, family history of cardiac disease, examination of the cardiovascular system; an ECG if there is past medical or family history of serious cardiac disease. Measure baseline, height, weight, blood pressure and pulse and baseline bloods.6 Initiate and stabilise treatment with atomoxetine. Stabilisation will usually take 6 to 12 weeks.7 Supply medication until care is transferred to GP.8 Ask the GP whether he or she is willing to participate in
Effective Shared Care Agreement (ESCA)Effective Shared Care Agreement • November 24th, 2017
This shared care agreement outlines suggested ways in which the responsibilities for managing the prescribing of atomoxetine in Attention- Deficit/Hyperactivity Disorder (ADHD) as part of a comprehensive treatment programme can be shared between the specialist and general practitioner (GP). You are invited to participate however, if you do not feel confident to undertake this role, then you are under no obligation to do so. In such an event, the total clinical responsibility for the patient for the diagnosed condition remains with the specialist.
Effective Shared Care Agreement (ESCA)Effective Shared Care Agreement • August 3rd, 2015
This shared care agreement outlines suggested ways in which the responsibilities for managing the prescribing of selegiline hydrochloride for parkinson's disease can be shared between the specialist and general practitioner (GP). You are invited to participate however, if you do not feel confident to undertake this role, then you are under no obligation to do so. In such an event, the total clinical responsibility for the patient for the diagnosed condition remains with the specialist.
Effective Shared Care Agreement for the treatment of Attention Deficit Hyperactivity disorder (ADHD) in Children and adolescents with METHYLPHENIDATEEffective Shared Care Agreement • February 11th, 2015
Specialist responsibilities 1 Discuss the benefits and side effects of treatment with the patient.2 Check for possible drug interactions with methylphenidate and patients regular medication. Avoid prescribing interacting drugs.3 Assess likelihood of compliance.4 Ensure patient is given sufficient information about their treatment.5 Perform all baseline tests including mental health and social assessment physical examination, including: assessment of history of exercise syncope, undue breathlessness and other cardiovascular symptoms heart rate and blood pressure weight; family history of cardiac disease and examination of the cardiovascular system; an ECG if there is past medical or family history of serious cardiac disease,6 Initiate and stabilise treatment with methylphenidate. Stabilisation will usually take 6 to 12 weeks.7 Supply medication until care is transferred to GP.8 Ask the GP whether he or she is willing to participate in shared care and explain the intention to share care
EFFECTIVE SHARED CARE AGREEMENT OF LITHIUM FOR THE TREATMENT OF MANIA, BIPOLAR DISORDER AND RECURRENT DEPRESSIONEffective Shared Care Agreement • August 2nd, 2021
Specialist Clinician responsibilities 1 Discuss the benefits and side effects of treatment with the patient.2 Check for possible drug interactions with lithium and patients regular medication. Avoid prescribing interacting drugs.3 Assess likelihood of compliance.4 Ensure patient is given sufficient information about their treatment. Ensure purple lithium booklet is given to patient.5 Perform all baseline tests as stated on the monitoring requirement.6 Initiate and stabilise treatment with lithium. Stabilisation will usually take 4- 8 weeks.7 Supply medication until care is transferred to GP. Lithium must be prescribed by specific brand.8 Ask the GP whether he or she is willing to participate in shared care and explain the intention to share care with patient/carer and obtain consent.9 Monitors appropriately as stated on the monitoring requirement. Ensure lithium levels are documented in purple lithium booklet or NHS lithium monitoring app which must be shown to dispensing pharmacy by p
Effective Shared Care Agreement (ESCA)Effective Shared Care Agreement • March 23rd, 2020
This shared care agreement outlines suggested ways in which the responsibilities for managing the prescribing of lithium can be shared between the specialist and general practitioner (GP). You are invited to participate however, if you do not feel competent to undertake this role, then you are under no obligation to do so. In such an event, the total clinical responsibility for the patient for the diagnosed condition remains with the specialist.
EFFECTIVE SHARED CARE AGREEMENTEffective Shared Care Agreement • August 11th, 2016
This shared care agreement outlines how the responsibilities for managing the prescribing of dronedarone for atrial fibrillation can be shared between the secondary care specialist and general practitioner (GP) / primary care prescriber. Dronedarone (Multaq®) is indicated in adult clinically stable patients with a history of, or current non-permanent atrial fibrillation (AF) to prevent recurrence of AF or to lower ventricular rate.
Effective Shared Care Agreement (ESCA)Effective Shared Care Agreement • August 3rd, 2015
This shared care agreement outlines suggested ways in which the responsibilities for managing the prescribing of sodium aurothiomalate for rheumatoid arthritis or psoriatic arthritis can be shared between the specialist and general practitioner (GP). You are invited to participate however, if you do not feel confident to undertake this role, then you are under no obligation to do so. In such an event, the total clinical responsibility for the patient for the diagnosed condition remains with the specialist.
Effective Shared Care Agreement (ESCA)Effective Shared Care Agreement • September 21st, 2015
This shared care agreement outlines suggested ways in which the responsibilities for managing the prescribing of eslicarbazepine acetate for epileptic seizures can be shared between the specialist and general practitioner (GP). You are invited to participate however, if you do not feel confident to undertake this role, then you are not obliged to do so. In such an event, the total clinical responsibility for the patient for the diagnosed condition remains with the specialist.
Effective Shared Care Agreement (ESCA)Effective Shared Care Agreement • July 1st, 2019
This shared care agreement outlines suggested ways in which the responsibilities for managing the prescribing of Fiasp® can be shared between the specialist and general practitioner (GP). You are invited to participate however, if you do not feel confident to undertake this role, then you are under no obligation to do so. In such an event, the total clinical responsibility for the patient for the diagnosed condition remains with the specialist.
Effective Shared Care Agreement (ESCA)Effective Shared Care Agreement • April 3rd, 2020
This shared care agreement outlines suggested ways in which the responsibilities for managing the prescribing of rufinamide for epileptic seizures can be shared between the specialist and general practitioner (GP). You are invited to participate however, if you do not feel competent to undertake this role, then you are under no obligation to do so. In such an event, the total clinical responsibility for the patient for the diagnosed condition remains with the specialist.
EFFECTIVE SHARED CARE AGREEMENT OF AZATHIOPRINE FOR THE TREATMENT OF INFLAMMATORY SKIN DISEASEEffective Shared Care Agreement • March 9th, 2016
Specialist responsibilities 1 Discuss the benefits and side effects of treatment with the patient.2 Check for possible drug interactions with azathioprine and patients regular medication. Avoid prescribing interacting drugs.3 Assess likelihood of compliance.4 Ensure patient is given sufficient information about their treatment.5 Perform all baseline tests (including FBC, U&Es, LFTs and TPMT assay).6 Initiate and stabilise treatment with azathioprine. Stabilisation will usually take at least 12 weeks.7 Supply medication until care is transferred to GP.8 Ask the GP whether he or she is willing to participate in shared care and explain the intention to share care with patient/carer and obtain consent.9 Monitors appropriately as stated on the monitoring requirement.10 Inform GP of the dose to be prescribed, any changes in dose, when to stop treatment and when to refer the patient back to specialist.11 Periodically review the patient’s condition and communicate promptly with the GP when tre
Effective Shared Care Agreement (ESCA)Effective Shared Care Agreement • August 3rd, 2015
This shared care agreement outlines suggested ways in which the responsibilities for managing the prescribing of azathioprine or mercaptopurine for inflammatory bowel disease refractory to 5ASA treatment and/or steroid dependent can be shared between the specialist and general practitioner (GP). You are invited to participate; however, if you do not feel confident to undertake this role, then you are under no obligation to do so. In such an event, the total clinical responsibility for the patient for the diagnosed condition remains with the specialist.
EFFECTIVE SHARED CARE AGREEMENT (ESCA): SOMATROPIN FOR THE TREATMENT OF GROWTH FAILURE IN CHILDRENEffective Shared Care Agreement • November 19th, 2021
Specialist responsibilities on initiation 1. Confirm diagnosis for one of the following:• Growth Hormone deficiency• Small for Gestational Age (SGA) with subsequent growth failure at 4 years of age or later• Short Stature Homeobox gene (SHOX) Deficiency• Turner Syndrome (TS)• Chronic Renal Insufficiency (CRI)• Prader-Wili Syndrome(PWS)2. Discuss the benefits and side effects of treatment with the patient.3. Check for possible drug interactions with somatropin and patients regular medication. Avoid prescribing interacting drugs4. Initiate somatropin and provide prescriptions for at least 3 months or until care is transferred to GP, usually after 3 months.5. Ask the GP whether he or she is willing to participate in shared care and explain the intention to share care with patient/carer and obtain consent.6. Inform GP of the dose to be prescribed, any changes in dose, when to stop treatment and when to refer the patient back to specialist.7. Inform GP if patient does not attend specialist
EFFECTIVE SHARED CARE AGREEMENT OF MYCOPHENOLATE FOR THE TREATMENT OF AUTOIMMUNE RHEUMATIC DISEASESEffective Shared Care Agreement • February 8th, 2021
Specialist clinician responsibilities 1 Discuss the benefits and side effects of treatment with the patient.2 Check for possible drug interactions with mycophenolate and patients regular medication. Avoid prescribing interacting drugs.3 Assess likelihood of compliance.4 Ensure patient is given sufficient information about their treatment.5 Perform all baseline tests (including FBC, U&Es and LFTs).6 Initiate and stabilise treatment with mycophenolate. Stabilisation will usually take 4 weeks.7 Supply medication until care is transferred to GP.8 Ask the GP whether he or she is willing to participate in shared care and explain the intention to share care with patient/carer and obtain consent.9 Monitors appropriately as stated on the monitoring requirement.10 Inform GP of the dose to be prescribed, any changes in dose, when to stop treatment and when to refer the patient back to specialist clinician.11 Ensure GP has access to blood results for information.12 Monitor for side effects and rep
Effective Shared Care Agreement (ESCA)Effective Shared Care Agreement • July 20th, 2017
This shared care agreement outlines suggested ways in which the responsibilities for managing the prescribing of oral antipsychotics can be shared between the specialist and general practitioner (GP). Oral antipsychotics are often an essential component of treatment for schizophrenia, schizoaffective disorder and bipolar affective disorder. Other indications for specific antipsychotics include psychotic depression and augmentation with antidepressants in severe depression. They can also be used for unlicensed indications including significant and distressing anxiety disorders including obsessive compulsive disorder, Tourettes syndrome and post-traumatic stress disorder. For such indications, specialist services should liaise closely with the GP and ensure that the GP understands the unlicensed/off label indication, the evidence supporting the proposed use and is happy to take on the prescribing.
EFFECTIVE SHARED CARE AGREEMENT OF SULFASALAZINE PLAIN AND ENTERIC COATED (EC) FOR THE TREATMENT OF ULCERATIVE COLITIS / CROHN’S DISEASE & AUTOIMMUNE RHEUMATIC DISEASES (EC only)Effective Shared Care Agreement • July 23rd, 2020
Specialist clinicians responsibilities 1 Discuss the benefits and side effects of treatment with the patient.2 Check for possible drug interactions with sulfasalazine and patient’s regular medication. Avoid prescribing interacting drugs.3 Assess likelihood of compliance.4 Ensure patient is given sufficient information about their treatment.5 Perform all baseline tests (including FBC, U&Es and LFTs).6 Initiate and stabilise treatment with sulfasalazine. Stabilisation will usually take 7 weeks.7 Supply medication until care is transferred to GP.8 Ask the GP whether he or she is willing to participate in shared care and explain the intention to share care with patient/carer and obtain consent.9 Monitors appropriately as stated on the monitoring requirements.10 Inform GP of the dose to be prescribed, any changes in dose, when to stop treatment and when to refer the patient back to specialist clinician.11 Ensure GP has access to blood results for information.12 Monitor for side effects and
Effective Shared Care Agreement (ESCA)Effective Shared Care Agreement • August 3rd, 2015
This shared care agreement outlines suggested ways in which the responsibilities for managing the prescribing of azathioprine for rheumatoid arthritis or psoriatic arthritis can be shared between the specialist and general practitioner (GP). You are invited to participate however, if you do not feel confident to undertake this role, then you are under no obligation to do so. In such an event, the total clinical responsibility for the patient for the diagnosed condition remains with the specialist.
Effective Shared Care Agreement (ESCA)Effective Shared Care Agreement • August 3rd, 2015
This shared care agreement outlines suggested ways in which the responsibilities for managing the prescribing of methotrexate in active Crohn’s disease despite repeated attempts to treat with steroids, 5 ASAs and azathioprine or 6-mercaptopurine can be shared between the specialist and general practitioner (GP). You are invited to participate however, if you do not feel confident to undertake this role, then you are under no obligation to do so. In such an event, the total clinical responsibility for the patient for the diagnosed condition remains with the specialist.
